New Hope for Drug and Diagnostics for TBI

Dr. Adrian Harel is an accomplished biochemist and business manager from Israel. He founded a company specializing in development of stem cell therapies for neurodegenerative diseases. Dr. Harel has a demonstrated record of accomplished and productive research projects in an area of high relevance for CNS breakdown. He has devoted considerable efforts into designing new molecules that could potentially help future victims of TBI and help the burden of societies endured by each TBI victim. It has been my lifelong mission to think outside the box and develop new treatments with his knowledge of biochemistry. See more at www.medicortex.fi